{
  "id": "a7bd93c986a81394",
  "title": "Medicaid has a new way to pay for costly sickle cell treatment : Only if it works",
  "description": "20260120T193000Z",
  "content": "",
  "source": "kazu.org",
  "source_url": "https://www.kazu.org/npr-news/2026-01-20/medicaid-has-a-new-way-to-pay-for-costly-sickle-cell-treatment-only-if-it-works",
  "published_at": "20260120T193000Z",
  "fetched_at": "2026-01-21T00:24:36.527019+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "ai"
  ],
  "location": "United States",
  "raw_data": {
    "url": "https://www.kazu.org/npr-news/2026-01-20/medicaid-has-a-new-way-to-pay-for-costly-sickle-cell-treatment-only-if-it-works",
    "url_mobile": "",
    "title": "Medicaid has a new way to pay for costly sickle cell treatment : Only if it works",
    "seendate": "20260120T193000Z",
    "socialimage": "http://npr-brightspot.s3.amazonaws.com/00/44/f6d86fd546399b1c98155d2569b7/sickle-cell-drugs-010.jpg",
    "domain": "kazu.org",
    "language": "English",
    "sourcecountry": "United States"
  }
}